We are live on ! Find out more
RUBY

Rubius Therapeutics, Inc

Delisted

RUBY was delisted on the 6th of March, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$170M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$44.4M +$6.05M +814,879 +9%
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$18.9M +$40.3K +5,430 +0.1%
AG
4
Artal Group
Luxembourg
$17.3M +$7.8M +1,050,000 +37%
BlackRock
5
BlackRock
New York
$13.4M -$643K -86,651 -3%
Vanguard Group
6
Vanguard Group
Pennsylvania
$13.4M +$117K +15,776 +0.5%
AVM
7
Arch Venture Management
Illinois
$11.7M
Capital World Investors
8
Capital World Investors
California
$7.84M -$25.4M -3,414,402 -66%
JP Morgan Chase
9
JP Morgan Chase
New York
$5.22M +$2.83M +381,422 +48%
HP
10
Harbourvest Partners
Massachusetts
$4.39M
State Street
11
State Street
Massachusetts
$2.92M -$49.9K -6,723 -1%
Federated Hermes
12
Federated Hermes
Pennsylvania
$2.67M +$2.04M +275,000 +85%
AFM
13
Abbot Financial Management
Massachusetts
$2.51M
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.45M +$284K +38,291 +7%
Northern Trust
15
Northern Trust
Illinois
$2.02M +$49.5K +6,665 +1%
Norges Bank
16
Norges Bank
Norway
$2M
Capital International Investors
17
Capital International Investors
California
$1.85M
AIM
18
ARK Investment Management
Florida
$1.42M -$2.69M -362,643 -53%
Charles Schwab
19
Charles Schwab
California
$950K +$21.9K +2,943 +1%
Nuveen
20
Nuveen
North Carolina
$873K +$8.48K +1,142 +0.6%
TCM
21
Tekla Capital Management
Massachusetts
$694K +$651K +87,609 +128%
Russell Investments Group
22
Russell Investments Group
United Kingdom
$656K +$1.1M +147,535 New
Citadel Advisors
23
Citadel Advisors
Florida
$625K -$390K -52,462 -27%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$583K -$64K -8,614 -6%
Ameriprise
25
Ameriprise
Minnesota
$517K +$11.8K +1,583 +1%